SUBSCRIBE
SUBSCRIBE

Convergent Therapeutics

NEWS
3D rendering of a Syringe Shield and multiple instances of the international radioactive hazard symbol or the trefoil icon.
Insights
The Brave New World of Radiotherapeutics
Convergent Therapeutics’ Dr. Philip Kantoff and Plus Therapeutics’ Dr. Marc Hedrick discuss how unmet medical needs, maturing isotope supply chains and innovative delivery are positioning targeted radiation as oncology’s next big platform.
April 1, 2026
 · 
4 min read
 · 
Jennifer C. Smith-Parker
syringe in a vial with a radioactive symbol against a background of antibodies
ADCs
rADCs Could Take Cancer Treatment ‘Magic Bullet’ to a New Level
Pharmaceutical companies are combining antibodies with radioisotopes in a bid to more precisely deliver radiation to cancers and tumors.
October 21, 2024
 · 
6 min read
 · 
Sruthi S. Balakrishnan
Map of NextGen Class of 2024/BioSpace
Business
NextGen Class of 2024: Top Life Sciences Startups to Watch This Year
Rapport Therapeutics tops this year’s list with $250 million in Series A and B financing in just six months.
January 3, 2024
 · 
20 min read
 · 
BioSpace Editorial Staff
IN THE PRESS
Press Releases
Convergent Therapeutics Appoints Radiopharmaceutical Industry Veteran Michael Rossi to its Board of Directors
March 19, 2026
 · 
3 min read
Press Releases
Convergent Therapeutics Appoints Elizabeth L. Montgomery Chief People Officer
January 29, 2026
 · 
2 min read
Press Releases
Convergent Therapeutics and NorthStar Medical Radioisotopes Announce Expanded Partnership to Support Convergent’s Late-Stage Alpha-Emitting Radioantibody Program
January 6, 2026
 · 
5 min read
Press Releases
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
November 18, 2025
 · 
9 min read
Press Releases
Convergent Therapeutics Announces Two Clinical Trial Updates on CONV01-α at the American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium 2025
February 11, 2025
 · 
4 min read
Press Releases
Convergent Therapeutics Appoints Barbara Duncan to Board of Directors
December 11, 2024
 · 
3 min read
Press Releases
Convergent Therapeutics Announces First Shipments of Actinium 225 from Cardinal Health to Support the CONVERGE-01 Phase 2 Clinical Trial
November 19, 2024
 · 
3 min read
Press Releases
Convergent Therapeutics Announces First Patient Treated in Phase II Clinical Trial with Lead Therapeutic Candidate and Corporate Updates
September 24, 2024
 · 
5 min read
Genetown
Convergent Therapeutics Announces FDA Clearance of IND Application for CONV01-α, a Best-in-Class Radioantibody Targeting Prostate-Specific Membrane Antigen
April 2, 2024
 · 
3 min read
Business
Convergent Therapeutics Appoints Scott Myers as Chairman of its Board of Directors
March 4, 2024
 · 
2 min read
AWARDS
  • NextGen Badge - Brighspot Rework_NextGen - Class of 2024.jpg
JOBS